Tellgen Corporation announced that the medical instruments registration application submitted by its wholly-owned subsidiary, Jiangxi Tellgen, has recently been accepted by the Jiangxi Province Food and Drug Administration. The accepted products in this application include a total of 6 items, such as the thrombin-antithrombin III complex assay kit and the thrombin regulation protein assay kit, all of which are chemiluminescent platform thrombosis detection products.